Home » FDA's SEQC Expands to Six Studies; RNA-seq Technical Reproducibility Work to Begin by Year End

FDA's SEQC Expands to Six Studies; RNA-seq Technical Reproducibility Work to Begin by Year End

Nov 29, 2011
Premium

By Bernadette Toner

An effort spearheaded by the US Food and Drug Administration to assess the technical reproducibility of next-generation sequencing platforms should begin generating data before the end of the year, with publication of results targeted for next spring, a project organizer told In Sequence.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

A Mammoth Competition

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Genetic History, Diversity

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

To Long Life

Researchers link genetic links between education and smoking and longevity.

This Week in PNAS

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.

What's Popular?

In Clinical Sequencing

  1. Illumina Ventures Raises $230M for First Fund

  2. Mission Bio Raises $10M in Series A Round

  3. Cornell Team Analyzing Cell-Free DNA, Single Cells to ID Transplantation Complications

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.